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ABSTRACT
Regulation of gene expression at the level of cyto-
plasmic polyadenylation is important for many bio-
logical phenomena including cell cycle progression,
mitochondrial respiration, and learning and mem-
ory. GLD4 is one of the non-canonical poly(A) poly-
merases that regulates cytoplasmic polyadenylation-
induced translation, but its target mRNAs and role
in cellular physiology is not well known. To assess
the full panoply of mRNAs whose polyadenylation
is controlled by GLD4, we performed an unbiased
whole genome-wide screen using poy(U) chromatog-
raphy and thermal elution. We identified hundreds of
mRNAs regulated by GLD4, several of which are in-
volved in carbohydrate metabolism including GLUT1,
a major glucose transporter. Depletion of GLD4 not
only reduced GLUT1 poly(A) tail length, but also
GLUT1 protein. GLD4-mediated translational control
of GLUT1 mRNA is dependent of an RNA binding
protein, CPEB1, and its binding elements in the 3′
UTR. Through regulating GLUT1 level, GLD4 affects
glucose uptake into cells and lactate levels. More-
over, GLD4 depletion impairs glucose deprivation-
induced GLUT1 up-regulation. In addition, we found
that GLD4 affects glucose-dependent cellular phe-
notypes such as migration and invasion in glioblas-
toma cells. Our observations delineate a novel post-
transcriptional regulatory network involving carbo-
hydrate metabolism and glucose homeostasis medi-
ated by GLD4.
INTRODUCTION
Dynamic and bidirectional regulation of poly(A) tail length
in the cytoplasm often regulates mRNA stability and trans-
lation. In addition to canonical nuclear poly(A) polymerase
(PAP), seven non-canonical PAPs catalyze the addition of
polynucleotides (adenosine or uridine): PAPD1 (mitochon-
drial PAP), RBM21 (Star-PAP/PAPD2/TUT6), ZCCHC6
(TUT7), ZCCHC11 (TUT4), GLD2 (germline develop-
ment 2, PAPD4/TUT2), GLD4 (PAPD5/TUT3/TRF4-2)
and POLS (PAPD7/TUT5) (1). Some of these PAPs have
specific subcellular localizations; for example, PAPD1 is
predominantly mitochondrial (2) whereas RBM21 is found
in nuclear speckles (3). Other PAPs such as ZCCHC6 and
ZCCHC11 mainly reside in the cytoplasm where they cat-
alyze terminal uridylation induced-mRNA degradation (4).
GLD2 is the most intensively studied member of this
family, and is linked to multiple biological pathways in
worms, flies, and mice (5–8); it lacks classical RNA binding
motifs and requires association with RNA binding proteins
to promote polyadenylation (9). GLD2 is bound to CPEB1
(cytoplasmic polyadenylation element binding protein 1),
which associates with 3′ UTR cytoplasmic polyadenylation
elements (CPEs). To form the cytoplasmic polyadenylation
ribonucleoprotein (RNP) complex, CPEB1 nucleates fac-
tors on mRNA such as GLD2 and PARN (poly(A) specific
ribonuclease) (10). Polyadenylation is induced by signal-
dependent phosphorylation of CPEB1, which results in the
dissociation of PARN, thereby allowing for GLD2 to cat-
alyze poly(A) addition (11) and resulting translational acti-
vation (11–13).
GLD4 and POLS are human homologues of yeast
Trf4/Trf5, which are involved in quality control of RNA
through polyadenylation and exosome-mediated degrada-
tion (14,15). Although the function of POLS is unknown,
GLD4 has a role in processing rRNA precursors (16) and
snoRNAs (17). It also regulates histone mRNA degrada-
tion in the cytoplasm (18), although another study observed
no such effect (19). The C-terminus of GLD4 contains sev-
eral basic amino acids that promote RNA binding indi-
cating that GLD4 is active without an RNA binding pro-
tein cofactor (20). PAR-CLIP (Photoactivatable Ribonu-
cleoside Enhanced Crosslinking and Immunoprecipitation)
analysis of ectopically-expressed GLD4 identified rRNAs,
but not mRNAs, as its main targets (20), suggesting cofac-
tors may be required for binding tomRNAs. Indeed, GLD4
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Figure 1. Unbiased genome-wide screen identifies GLD4-regulated mRNAs. (A) Analysis of GLD4 protein localization. HEK 293T cells were transfected
with GFP-CPEB1 and FLAG-GLD4, and immunostained with GFP (green) and FLAG (red) antibodies. (B) The same cells as in (A) were used for co-
immunoprecipitation. FLAG-GLD4 was immunoprecipitated with IgG or FLAG antibody in the presence or absence of RNase A, and immunoblotted
for FLAG, GFP and GAPDH. (C) Venn-diagram showing overlap of 74 mRNAs between the 387 that were differentially expressed in 65◦C thermal
elution fraction and the 458 that were differentially expressed in the total input fraction. (D) RNA from siNT or siGLD4-treated human primary foreskin
fibroblasts was fractionated on poly(U) agarose, thermally eluted at 65◦C and then subjected to microarray analysis. All 14666 detected RNAs were plotted
as log2 fold change (abscissa) versus –log10P-value (ordinate) in GLD4 knockdown cells compared to control cells. 387 down-regulated RNAs in the 65◦C
fraction with P-value <0.05 are highlighted in red (see Supplementary Table S2). Four GLD4 target mRNAs (GLUT1, PFKFB3, PFK-1 and ENO1) are
also labeled. (E) A schematic diagram showing glucose uptake, glycolysis and P53 pathways and GLD4 regulated RNAs (labeled in red; see main text
for full name of the enzymes). G6P, glucose-6-phosphate; 6-PGL, 6-phosphoglconolactone; NADP, nicotinamide adenine dinucleotide phosphate; F6P,
fructose-6-phosphate; F2,6P2, fructose-2,6-biphosphate; F1,6P2, fructose-1,6-biphosphate; G3P, glyceraldehyde-3-phosphate.
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interacts with P53 mRNA in a CPEB1-dependent manner,
and depletion of GLD4 or CPEB1 reduces P53 mRNA
polyadenylation-induced translation and consequent by-
pass of cellular senescence (21,22).
Although the nuclear function of GLD4 has been ex-
plored (16,17), its role in the cytoplasm is largely un-
known. The fly ortholog Trf4-1 is involved in cytoplas-
mic oligoadenylation-mediated exosomal mRNA degrada-
tion in Drosophila cells (23). In Caenorhabditis elegans,
GLD4 (worm ortholog of human GLD4/PAPD5 and
POLS/PAPD7) localizes in the cytoplasm where it forms a
complex with gls-1 to promote translation of glp-1 mRNA
and maintains germ cell proliferation (24). The molecular
function of the mammalian orthologs of gls-1, ZCCHC14
and ZCCHC2, is unknown. A genome-wide polysome pro-
filing analysis of gld-4(RNAi) animals revealed that GLD4
only mildly changes bulk mRNA poly(A) tail extension,
but that it may actively promote general translational effi-
ciency in C. elegans (25). With the exception of P53, molec-
ular targets of GLD4-mediated cytoplasmic polyadenyla-
tion as well as the biological pathways GLD4 controls are
largely unidentified in vertebrates. Based on previous stud-
ies (22), we hypothesized that GLD4 regulates poly(A) tail
length of several mRNAs, and consequently sought to iden-
tify them in human cells as well as the cellular pathways
they may control. In our analysis, we found hundreds of
GLD4-regulated mRNAs including several in the carbohy-
dratemetabolism pathway. One of these is the glucose trans-
porter GLUT1 (SLC2A1), which we show is crucial for cel-
lular glucose uptake and affects cellular migration. More-
over, we found that GLD4 regulates glucose deprivation-
mediated GLUT1 expression. These observations suggest
that GLD4 regulates glucose metabolism and homeostasis
via regulating gene expression at the level of cytoplasmic
polyadenylation-mediated translation.
MATERIALS AND METHODS
Cell culture
Human foreskin fibroblasts (Yale Skin Disease Research
Center), U87MG human glioblastoma cells (a Gift of Dr
Alonzo Ross, University ofMassachusetts Medical School)
andHEK293Thuman embryonic kidney cells (ATCC)were
cultured in DMEM supplemented with 10% FBS and 1%
antibiotic/antimycotic compounds.
Thermal elution and microarray analysis
Total RNA from human foreskin fibroblasts was extracted
with TRIzol reagent (Invitrogen). Polyadenylated RNAs
were bound to poly(U) agarose beads (Sigma), washed at
50◦C, and eluted at 65◦C (8). Total RNA (input) as well
as RNA from the thermally eluted fraction were precipi-
tated and contaminants removed by an RNeasy MinElute
purification kit (Qiagen). The purified RNAs were used as
templates to synthesize biotin-labeled cRNAs that were an-
nealed to the humanHT-12 Expression BeadChip array (Il-
lumina), which was performed at the Genomics core facil-
ity of the Pennsylvania State University. Differentially ex-
pressed RNAs were analyzed with Genespring Suite (Ag-
ilent Technologies) using unpaired asymptotic T-test (P-
value < 0.05) and were deposited in Gene Expressing Om-
nibus (accession number: GSE77747).
PCR primers
All oligonucleotide sequences for PCR are provided in the
Supplementary Table S1.
Lentivirus
shRNAs against GLD4 and GLUT1 were cloned into
pLL3.7 (syn) lentivirus vector in which the CMV pro-
moter is replaced with a synapsin promoter (8). Lentiviral
shRNAs targeting GLD2 and CPEB1 are described else-
where (8). Targeting sequences for shGLD4 and shGLUT1
are provided in the Supplementary Table S1.
Wound healing assay
Twenty thousandU87MG glioblastoma cells were plated in
each well of a six-well plate, and were infected lentiviruses
expressing shRNA after 1 day. After 3 days, the cultured
cells were scratched with a 200 ul pipette tip and cell migra-
tion was first assessed and pictured after 12 hours (h), and
then every 6 h thereafter. The wound area was measured us-
ing TScratch, a software tool to analyze wound healing as-
says developed by the CSElab. The details of the assay are
in Supplementary Experimental Procedure.
Statistical analyses
Statistical analyses were performed with Student’s t-test as
indicated in the figure legends.
RESULTS
Some studies suggest that GLD4 is a component of the nu-
clear exosome complex (16,20,26); others, however, indicate
that it has cytoplasmic functions (18,22–25). After unsuc-
cessful attempts to detect endogenous GLD4 and CPEB1
by western blotting, we ectopically expressed tagged ver-
sion of these proteins to determine their cellular localiza-
tion. FLAG-GLD4 was nearly exclusively cytoplasmic as
was GFP-CPEB1 (Figure 1A), which is a known cyto-
plasmic RNA-binding protein. Moreover, GLD4 was co-
immunoprecipitated with CPEB1, but not the negative con-
trol GAPDH, in the presence of RNase A (Figure 1B) indi-
cating GLD4 interacts with a cytoplasmic polyadenylation
factor.
In human primary foreskin fibroblasts, GLD4 promotes
polyadenylation and translation of P53 mRNA (22). How-
ever, other GLD4 target mRNAs are largely unknown.
To identify mRNAs whose polyadenylation is controlled
by GLD4, we employed poly(U) agarose chromatography,
a procedure in which RNA bound to poly(U) beads is
washed at 50◦C and then collected at 65◦C. Generally, mR-
NAs with relatively short poly(A) tails (∼50 nucleotides)
elute at 50◦C whereas RNAs with longer tails predomi-
nantly elute at a higher temperature (Supplementary Fig-
ure S1A). Primary human fibroblasts were transfected with
non-targeting siRNA (siNT) or siRNA targeting GLD4
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Figure 2. GLD4 regulates GLUT1 poly(A) tail length and protein levels. (A) U87MG cells were transfected with plasmids carrying FLAG epitope only,
FLAG-GLD4, or FLAG-CPEB1. After immunoprecipitation with FLAG antibody, extracted RNAs were subjected to RT-PCR for GLUT1 and P53
transcripts. GAPDH is a negative control. (B) U87MG cells were transfected with siNT and siGLD4 for 24 h, and they were subjected to RL-PAT assay
to measure poly(A) tail size of GLUT1 mRNA. Relative signal intensity was quantified to estimate median poly(A) tail size (median ± SEM) (n = 3). (C)
U87MG cells were transfected with siNT and siCPEB1 for 24 h, and were subjected to RL-PAT assay (median ± SEM) (n = 3). (D) U87MG cells were
transduced with shNS, or shRNAs targeting GLD2, GLD4 and CPEB1. GLD4#1 and #2 indicate two separate shRNAs targeting different regions of
GLD4. After 72 h after transduction, these cells were subjected to RT-PCR tomeasure knockdown efficiency of each shRNA andGLUT1mRNA.GLUT3
mRNA was not changed and served as a control. (E) The same set of cells as in (D) was used for immunoblot analysis for GLUT1 and GLUT3 protein.
eIF4E and GAPDH served as loading controls. (F) Quantification of relative GLUT1 protein with knockdown of GLD2, GLD4 and CPEB1 (mean ±
SEM) (n = 3). (G) RNA reporter constructs used to measure translation efficiency. m7G denotes 7-methyl-guanosine cap structure. Solid line and black
columns represents untranslated region (UTR) and CPE, respectively. (H) siNT and siGLD4 treated U87MG cells were transfected with Renilla luciferase
RNA harboring GLUT1 3′UTR and firefly luciferase as a transfection control. After 6 h, cells were harvested and measured for luciferase activity (R/F)
(mean ± SEM) (n = 6). (I) The same set of cells as in (H) was used to assess the relative amount of RNA (R/F) (mean ± SEM) (n = 3) by real-time PCR.
(J) Translation efficiency is calculated by dividing numbers from (H) with those from (I).* indicates P < 0.05, ** indicates P < 0.01 and *** indicates P <
0.001 by two-tailed Student’s t-test.
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(siGLD4), which reduced GLD4 mRNA levels by ∼60%
(Supplementary Figure S1B). Total RNA from three bio-
logical replicates were subjected to poly(U) chromatogra-
phy and thermal elution followed by microarray analysis.
Depletion of GLD4 would be expected to result in short-
ened poly(A) tails and hence the target RNAs would be
reduced in the 65◦C eluted fraction. Figure 1C demon-
strates that many RNAs (highlighted in red) were sig-
nificantly reduced in the 65◦C eluate. Surprisingly, other
RNAs were increased in that same RNA fraction. Here,
we focused on 387 RNAs that were significantly down-
regulated (P-value <0.05 by student’s t-test) in the 65◦C
fraction (Supplementary Table S2). Of these 387 mRNAs,
74 were also reduced in the input RNA indicating not all
the changes in the 65◦C eluted fraction are due to short-
ened poly(A) (Figure 1D). The decreased expression lev-
els of five selected mRNAs were confirmed by RT-qPCR
(Supplementary Figure S1C). Gene ontology (GO) analy-
sis of the down-regulated mRNAs identified carbohydrate
metabolism as one of the enriched biological processes in
this set of RNAs (Supplementary Figure S1D). Among
these were a glucose transporter and many glycolytic en-
zymes (Figure 1E, labeled in red) such asGLUT1 (facilitated
glucose transporter 1), G6PD (glucose-6-phosphate dehy-
drogenase), PFKFB3 (6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase), PFK-1 (phophofructokinase-1), GK
(glycerol kinase), TALDO1 (transaldolase 1) and ENO1
(enolase 1). In addition, a known target mRNA of GLD4,
P53was also detected as a down-regulated RNA along with
NQO1 (NAD(P)H dehydrogenase, quinone 1), which stabi-
lizes P53 protein (27). These results suggest a role of GLD4
in carbohydrate metabolism by regulating 3′ end modifica-
tion of specific mRNAs.
GLD4 and CPEB1 control GLUT1 mRNA polyadenylation
and translation
The central role of CPEB1 in cytoplasmic polyadenylation
is to connect target RNAswith poly(A) polymerases. A spe-
cific RNA element in 3′UTRs of mRNAs, the cytoplasmic
polyadenylation element (CPE, consensus sequence UU-
UUAU or UUUUAAU) (10), is responsible for interac-
tion with CPEB1. Many of the GLD4 targets in the car-
bohydrate metabolism have CPEs in their 3′ (Supplemen-
tary Figure S2A). To test whether the identified GLD4
target mRNAs involved in glucose metabolism are associ-
ated with CPEB1, RNA-immunoprecipitation with FLAG-
CPEB1was performed (Supplementary Figure S2B). As ex-
pected, CPE-lacking RNAs did not interact with CPEB1
(G6PD, ENO1). Interestingly, some of the CPE-containing
RNAs were associated with CPEB1 as expected (GLUT1,
P53) while others were not (PFKFB3, PFK-1) (Supplemen-
tary Figure S2B) suggesting possible interactions with other
RNA-binding proteins. We focused on GLD4 regulation of
GLUT1 mRNA because GLUT1 is the starting point of
glucose uptake and subsequent glycolytic processes and be-
cause the transcript interacts with CPEB1 (Figure 1E and
Supplementary Figure S2B). GLUT1 is expressed in many
cell types including erythrocytes, endothelial cells that form
the blood-brain barrier, astrocytes, and several tumor types
(28). Its major function is to maintain cellular glucose con-
centration, and mutations in this gene lead to a neurode-
velopmental disorder, GLUT1 deficiency syndrome-1 (29),
which is characterized by impaired brain function.
To investigate GLD4 and CPEB1 in GLUT1mRNA reg-
ulation, we used U87MG astrocytoma cells, which have a
defined glucose-sensitive metabolism (30). RNA-seq anal-
ysis of these cells showed that GLD4 RNA in U87MG
cells is moderately abundant (14.14 TPM; transcripts per
million) and ranked 7665th among 14473, and is compa-
rable to other genes involved in cytoplasmic polyadenyla-
tion (GLD2: 24.36 TPM; CPEB1: 42.12 TPM) (Supple-
mentary Figure S2C). To investigate GLD4 and CPEB1 in-
teraction with GLUT1 mRNA, FLAG-GLD4 or FLAG-
CPEB1 complexes were co-immunoprecipitated and the ex-
tracted RNA was analyzed for GLUT1, P53 (positive con-
trol), and GAPDH (negative control) sequences by RT-
PCR. Both FLAG-GLD4 and FLAG-CPEB1 were co-
immunoprecipitated with GLUT1 mRNA (Figure 2A).
CPEB1 knockdown impaired the interaction between
GLD4 andGLUT1mRNA, indicating thatGLUT1mRNA
is anchored to GLD4 in a CPEB1-dependent manner (Sup-
plementary Figure S2D). We surmised that GLD4 binds
to the GLUT1 mRNA by interacting with CPEB1 and the
change in GLUT1 levels in the 65◦C eluted fraction (but
not in total input) was due to shortened poly(A) tail of the
GLUT1 mRNA following knockdown of GLD4. To vali-
date this hypothesis, we performed an RNA-ligation cou-
pled, PCR-based poly(A) tail length (RL-PAT) assay to in-
dependently measure tail size of theGLUT1 mRNA. As ex-
pected, we observed a shortened tail length of the GLUT1
mRNA upon GLD4 or CPEB1 depletion (Figure 2B and
C, Supplementary Figure S3A and S3B).
Next we examined the consequence ofGLUT1 tail length
shortening following GLD4 or CPEB1 knockdown. Be-
cause elongated poly(A) tails are associated with elevated
translation of various mRNAs (10), we speculated that
GLD4 or CPEB1 knockdown would result in decreased
production of GLUT1 protein. Western blot analysis of
cells transduced with shRNA lentivirus targeting two dif-
ferent regions of GLD4 (Figure 2D, lanes 3 and 4) showed
a ∼50% reduction of GLUT1 (Figure 2E, lanes 3 and
4; quantification in Figure 2F). Surprisingly, the level of
GLUT3, whose mRNA polyadenylation was also reduced
by GLD4 depletion (Supplementary Table S2), was un-
affected by GLD4 knockdown, demonstrating that not
all the RNAs identified in the screening have commensu-
rate changes in protein levels (Figure 2E). Cells treated
with shRNA lentivirus targeting CPEB1 also had a simi-
lar ∼50% reduction of GLUT1 (Figure 2E, lane 5; quan-
tification in Figure 2F, lane 5). In contrast, knockdown of
GLD2 had no effect on GLUT1 (Figure 2E and F, lane
2) showing specificity of target selection by PAPs. GLUT1
mRNA levels were not changed by GLD4 or CPEB1 deple-
tion (Figure 2D), suggesting that the regulation of GLUT1
occurs at the translational level. In concordance to our data
with shRNA, depletion of GLD4 with siRNAs also re-
duced GLUT1 levels (Supplementary Figure S3C–E). To
support ourmodel ofGLD4-mediated translational control
ofGLUT1mRNA,we employed a separate translational as-
say using a reporter RNA harboring the 3′ UTR ofGLUT1
mRNA (Figure 2G). The luciferase activity derived from
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Figure 3. CPEB1 regulates GLUT1 translation. (A) Schematic diagram for the 3′ UTR of the GLUT1 mRNA. The rectangle indicates the open reading
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as competitors of RNA-IP reactions. After immnoprecipitation with HA antibody, RNAs were subjected to real-time PCR for the levels of GLUT1 RNA
and normalized to 28S rRNA to quantify fold enrichment in each condition. The experiments were performed three times and one representative result is
shown here. (C) The relative competition efficiency was calculated compared to the reaction without any competitor (mean± SEM) (n= 3). (D) Schematic
diagram of RNA reporter constructs. Three vertical black bars in GLUT1 3′UTR denote CPEs, and white bars indicate lack of CPEs. (E) U87MG cells
were transfected with a luciferase reporter harboring GLUT1 3′ UTR containing or lacking three CPEs. After 6 h, relative Renilla luciferase (R) to firefly
(F) activity was measured (R/F) (mean ± SEM) (n = 5). (F) The same set of cells as in (E) was used to assess the relative amount of RNA (R/F) (mean ±
SEM) (n= 4) by real-time PCR. (G) Translation efficiency is calculated by dividing numbers from (E) with those from (F).* indicates P< 0.05, ** indicates
P < 0.01 and *** indicates P < 0.001 by two-tailed Student’s t-test.
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Figure 4. GLD4 regulates glucose metabolism. (A) U87MG cells were
transduced with shNS, or shRNAs targeting GLD4 or CPEB1 and mea-
sured for glucose uptake (mean ± SEM) (n = 4) after 72 h. (B) U87MG
cells were transduced with lentivirus expressing empty vector (control)
or a GLUT1 expressing vector and 24 h later the same cells were trans-
fected with siNT or siGLD4. After 48 h, cells were measured for glucose
uptake (mean ± SEM) (n = 3). (C) U87MG cells were transfected with
siNT or siGLD4 and measured for lactate levels (mean ± SEM) (n = 4).
(D) U87MG cells were transduced with lentivirus expressing empty vector
(control) or a GLUT1 expressing vector and 24 h later the same cells were
treated with siNT or GLD4. After 48 h, cells were measured for lactate
levels (mean ± SEM) (n = 4). * indicates P < 0.05, ** indicates P < 0.01
and *** indicates P < 0.001 by two-tailed Student’s t-test.
the reporter was reduced 20% upon GLD4 depletion with-
out affecting the luciferase RNA level, indicating transla-
tional control of GLUT1 mRNA by GLD4 (Figure 2H–J).
As indicated above, CPEB1-mediated cytoplasmic
polyadenylation requires the 3′ UTR cytoplasmic
polyadenylation element (CPE, consensus sequence
UUUUAU) (10). We found three CPEs in a 40 nucleotide
window (Figure 3A) of the 1.7 kb GLUT1 3′UTR, which
are conserved among mammals (Supplementary Figure
S4A). To determine whether these sequences are CPEB1
binding sites, we performed an RNA-IP competition assay
using HA-CPEB1 expressed in U87MG cells with GLUT1
3′ UTR containing or lacking three CPEs as competitors.
Following immunoprecipitation of CPEB1-RNA com-
plexes, the extracted RNA was analyzed for enrichment of
endogenous GLUT1 mRNA relative to 28S rRNA (Figure
3B), and the relative competition efficiency by competitor
RNA was calculated (Figure 3C). The exogenous GLUT1
3′ UTR containing CPEs competed ∼65% of endogenous
GLUT1 mRNA whereas GLUT1 3′ UTR lacking CPE
(-CPE) competed less efficiently (∼35%) (Figure 3C). To
determine the importance of the CPEs in translational
regulation of GLUT1mRNA, we performed an assay using
reporter RNAs of GLUT1 3′ UTR containing or lacking
CPEs (Figure 3D). As expected, a reporter RNA without
CPEs binds to CPEB1 less efficiently than a reporter with
CPEs (Supplementary Figure S4B). A reporter RNA with
GLUT1 3′ UTR lacking CPEs (-CPE) was translated
20% less efficiently than CPE-containing GLUT1 3′ UTR
without affecting the reporter RNA level (Figure 3E–G),
indicating these 3 CPEs of GLUT1 3′ UTR are important
for translational regulation by CPEB1. Interestingly, the
40 nucleotides containing the three CPEs is sufficient to
enhance translation as assessed by the use of a reporter
RNA containing this region, which has a significantly
higher translational efficiency than reporter that lacks this
region (Supplementary Figure S5A-C). The reporter RNA
containing the 40 nucleotide region with a mutant version
of CPEs did not show the translational enhancement,
indicating that the CPEs are important for the translation
efficiency (Supplementary Figure S5C).
GLD4-mediated polyadenylation regulates glucose home-
ostasis
Because GLUT1 is a major glucose transporter and is re-
sponsible for the maintenance of basal glucose levels (28),
we speculated that reduced GLUT1 resulting from GLD4
knockdown would diminish glucose uptake into cells. To
assess this possibility, cells transduced with lentivirus ex-
pressing a non-specific (NS) shRNA or shRNAs against
GLD4 or CPEB1 were starved for glucose for 2 h and then
incubated with the glucose analog [3H]2-deoxyglucose. Up-
take of the glucose analog was reduced by ∼25% following
GLD4 or CPEB1 depletion (Figure 4A). Similar reductions
of glucose uptake were observed when the cells were trans-
fected with siGLD4 (Figure 4B, lanes 1 and 3, and Supple-
mentary Figure S6). The reduced glucose uptake was res-
cued when GLUT1 was ectopically expressed in the GLD4-
depleted cells (Figure 4B, lanes 3 and 4) indicating GLD4
control of glucose uptake is mediated by GLUT1. Because
glucose is the major fuel source for energy through glycoly-
sis that leads to production of other metabolites such as lac-
tate (Figure 1E), we surmised that reduced glucose uptake
following GLD4 knockdown would reduce lactate, which
indeed occurred (Figure 4C). Reduced lactate was rescued
by the ectopic expression of GLUT1 suggesting GLD4 reg-
ulation of lactate is mediated by GLUT1 (Figure 4D, lanes
3 and 4).
GLUT1 levels are dynamically regulated to maintain cel-
lular glucose homeostasis (31). Previous studies indicate
that increased GLUT1 mRNA stability upon glucose de-
privation is mediated by the mRNA’s 3′ UTR, suggesting
that poly(A) tail lengthening may be an underlying molec-
ular mechanism (32). Indeed, glucose deprivation triggers
an up-regulation of GLUT1 protein to facilitate the effi-
cient uptake of glucose (Figure 5A, lanes 1–3), which con-
firms previous observations (31–33). In glucose-deprived
cells, GLUT1 increased by∼4-fold compared to cells main-
tained with constant high glucose (Figure 5A and B, lanes
1–3). In contrast, GLUT1 mRNA triggered by glucose de-
privation changed <2-fold (Figure 5C lanes 1–3) indicat-
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Figure 5. GLD4 regulates glucose deprivation-inducedGLUT1 expression. (A) GLUT1 protein levels upon glucose deprivation (Glu–) in control (siNT) or
GLD4knockdownU87MGcells (siGLD4). 0 h rindicates pre-deprivation andGlu+ indicates a non-deprivation control.Glu– indicates glucose deprivation
for 24 h. EIF4E andGAPDHwere used as loading controls. (B) Relative GLUT1 protein levels were quantified compared to 0 h of the control cells (mean±
SEM) (n= 6). (C) The same set of cells as (B) was subjected to RT-qPCR to test GLUT1mRNA levels. (D) Relative GLUT1 protein synthesis is calculated
by dividing numbers from (B) with those from (C). * indicates P < 0.05, ** indicates P < 0.01 and *** indicates P < 0.001 by two-tailed Student’s t-test.
ing at least half of the up-regulation of GLUT1 occurred at
the translational level (Figure 5D, lanes 1–3, GLUT1 pro-
tein to mRNA). The remaining up-regulation of GLUT1
is unlikely to be due to a transcriptional change but in-
stead probably due to increased stability, which we infer
from the observation that the GLUT1 pre-mRNA level was
not changed (Supplementary Figure S7A). Interestingly, a
subtle but significant increase of GLUT1 mRNA poly(A)
tail length was observed upon glucose depletion, indicating
that cytoplasmic polyadenylation is involved in the GLUT1
protein up-regulation (Supplementary Figure S7B, lanes 1
and 2). We next investigated whether GLD4 helps maintain
glucose homeostasis by regulating GLUT1 following glu-
cose depletion. When cells were transfected with siGLD4,
the up-regulation of GLUT1 induced by glucose depriva-
tion was suppressed ∼50% compared to siNT (Figure 5A
and B, lanes 3 and 6). Moreover, depletion of GLD4 ham-
pers increase of GLUT1 mRNA poly(A) tail under glucose
deprivation (Supplementary Figure S7B). These data indi-
cate that the GLD4-GLUT1 axis is a component of the glu-
cose homeostasis mechanism.
Given the importance of GLD4 and its interacting part-
ner CPEB1 in GLUT1 regulation and glucose metabolism,
we speculated that GLD4 and CPEB1 may regulate cellular
physiologies that are sensitive to the glucose utilization such
as cell migration (34,35). Consequently, we tested whether
GLD4 or CPEB1 controls this process in a wound-healing
assay that measures the rate of cell infiltration into a scratch
made in confluent cells (36). To ensure U87MG cell migra-
tion is directly affected by GLUT1, we first tested cell mi-
gration of GLUT1-depleted cells. Following infection with
lentivirus expressing a NS shRNA, or shRNAs against two
different regions ofGLUT1 (Figure 6B), confluent cells were
scratched and the rate of infiltration into the wounded area
was measured after 12, 18 and 24 h. At 18 and 24 h, deple-
tion of GLUT1 significantly delayed mobility of cells into
the wound (Figure 6A and C). Next, we tested effects of de-
pletion of GLD4 or CPEB1 on cell migration. At 18 and
24 h, depletion of GLD4 or CPEB1 significantly delayed
mobility of the cells into wound (Figure 6D and E). More-
over, depletion of GLD4 also elicited a decrease in transwell
cell invasion through Matrigel, which is a surrogate base-
ment membrane (Figure 6F). In contrast, neither GLD4
nor CPEB1 affected the rate of cell proliferation (Figure
6G). These data indicate that GLD4-mediated translational
control of GLUT1 mRNA regulates not only cellular glu-
cose metabolism, but also the glucose-related cell migration
and invasion.
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Figure 6. GLD4 and GLUT1 regulate cell migration. (A) U87MG cells were infected with shNS or lentivirus expressing two different GLUT1 shRNAs.
After 72 h, cells were subjected to wound healing assays. Images were captured 12, 18 and 24 h after the initial wound. Images from each time point
are shown for graphical representations of wound healing ability. (B) Knockdown efficiency of two different shRNAs targeting GLUT1 was analyzed by
western blot. eIF4E and GAPDHwere negative controls. (C) Quantification of the relative wound area after 0, 12, 18 and 24 h after initial wound (mean±
SEM) (n= 6). (D) Wound healing assay as described in (A) was performed for shNS, shGLD4 or shCPEB1 infected cells. (E) Quantification of the relative
wound area (mean ± SEM) (n = 6). (F) Matrigel invasion assays with U87MG cells infected with lentivirus expressing the indicated shRNAs (mean ±
SEM) (n = 3). (G) Proliferation rate of the shRNA knockdown cells 24 and 48 h post-infection (mean ± SEM) (n = 4). * indicates P < 0.05, ** indicates
P < 0.01 and *** indicates P < 0.001 by two-tailed Student’s t-test.
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DISCUSSION
The glucose transporter GLUT1 is widely expressed and
is important for basal level glucose uptake. Aberrant ex-
pression of GLUT1 is detected in various disease con-
ditions such as experimentally induced diabetes in ani-
mals, Alzheimer’s disease and certain cancers where ele-
vated GLUT1 is associated with a poor prognosis (37–41).
Inhibition of GLUT1 expression as well as targeting of the
enzyme by small molecules impairs growth of various can-
cers, indicating a pivotal role of GLUT1 in oncogenesis
(42,43). Despite the fact that multiple glucose transporters
are expressed in a variety of cell types, GLUT1 seems to
have non-redundant functions in several of them (44,45).
In addition, heterozygous mutations in this gene lead to a
neurodevelopmental disease, GLUT1 deficiency syndrome-
1, which is diagnosed by low glucose and lactate levels in
cerebrospinal fluid (29).
Our data demonstrate that the CPEB1-GLD4 cyto-
plasmic polyadenylation complex binds to and facilitates
translation of GLUT1 mRNA. Consequently, depletion
of GLD4 reduces glucose uptake and lactate production.
Our data also indicate that although GLD4 and CPEB1
knockdown had no effect on the proliferation/cell death
of U87MG cells, it attenuated cell migration and invasion.
These results agree with a previous observation that ectopic
expression of a dominant negative CPEB1 reduces cell mi-
gration in rat glioblastoma cells (46). On the other hand,
CPEB1 depletion promotes cell migration in breast can-
cer cells, suggesting that it can have opposite effects de-
pendent on cell type (47). This duality is also illustrated
by GLD4, which promotes translation of the major tumor
suppressor P53 on one hand and translation of GLUT1
on the other, thereby simultaneously regulating seemingly
opposing metabolic pathways. These observations suggest
versatile regulation of biological pathways by cytoplasmic
polyadenylation; that is, cells may be equipped with a mul-
tifaceted system that they can rapidly adapt to necessary
changes by targetingmultiple (sometimes contradictory) bi-
ological pathways depending on the biological context.
In addition to GLUT1, GLD4 regulates the poly(A) tails
of a number of mRNAs that are involved in carbohy-
drate metabolism including G6PD, PFKFB3, PFK-1, GK,
TALDO1 and ENO1. These genes encode essential gly-
colytic enzymes that convert glucose to pyruvate for en-
ergy production. The coordinated regulation of a cohort
of enzymes in this pathway by GLD4 is reminiscent of the
CPEB1-mediated regulation of multiple components in the
insulin-signaling pathway (48).While not all of the mRNAs
that we identified in this study are likely to be directly reg-
ulated by GLD4, it is remarkable that expression of several
key enzymes in a single physiological pathway was affected
by depletion of GLD4.
The changes in poly(A) tail length by GLD4 depletion
were often <50%, which is of the same general magni-
tude as observed in neurons depleted of GLD2, another
non-canonical PAP (8). The change in poly(A) tail size by
GLD4 knockdown may be partly attributable to the fact
that the cells we used were not stimulated. Indeed, GLD2-
or CPEB1-mediated cytoplasmic polyadenylation is robust
when cells respond to external signaling cues such as dur-
ing development or upon synaptic activation, or stimula-
tion of the acute inflammatory response (10). These obser-
vations suggest that a more substantial change in GLD4-
mediated cytoplasmic polyadenylation may be associated
with environmental cues such as hormone or stress-induced
signaling. Therefore, investigation of GLD4-mediated cyto-
plasmic polyadenylation under various physiological con-
texts may identify different sets of GLD4-regulated mR-
NAs from those mRNAs identified in this study. GLD4
is widely expressed suggesting possible broad roles in vari-
ous biological processes. The tail length changes we observe
are consistent with studies from C. elegans where GLD4–
compromised animals have slightly shorter poly(A) tails
(25,49). Interestingly, these animals have profound defects
in polysome assembly suggesting a role of GLD4 in pro-
moting general protein synthesis (25).
It is evident that a number of mRNAs regulated by
GLD4 at the level of cytoplasmic polyadenylation do
not interact with CPEB1, suggesting the involvement of
other RNA binding proteins in GLD4-mediated cytoplas-
mic polyadenylation (Supplementary Figure S2B). Bidirec-
tional regulation of poly(A) tail length involves combina-
torial interactions of RNA binding proteins, deadenylases,
and poly(A) polymerases. Multiple RNA binding proteins
are thought to drive cytoplasmic deadenylation (50) includ-
ing the AU-rich element (ARE) binding protein, KSRP
and TTP, PUF family members Pumilio and FBF, as well
as a GU-rich sequence binding protein CUG-BP (51,52).
Whether polyadenylation similarly involvesmultiple factors
that differentiate cis-elements of mRNAs is less clear except
for a few examples inC. elegans andXenopus (53,54). There-
fore, decoding the polyadenylation network woven by RNA
binding proteins interacting with GLD4 is a necessary next
step.
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